Survey Research on Use of Etoposide as First Line of Treatment for Lung Cancer in Europe - Business Intelligence

Survey Research on Use of Etoposide as First Line of Treatment for Lung Cancer in Europe

Pharmaceutical Industry

Survey Research on Use of Etoposide as First Line of Treatment for Lung Cancer in Europe

Business Challenge A leading cancer drug manufacturer wanted to understand the level of acceptance of etoposide as the first line of treatment for lung cancer. Situation The client wanted to analyze the trend of using platinum doublet chemotherapy with etoposide for the first-line of treatment of patients with unresectable, locally advanced, stage III, non squamous, […]

READ MORE >>

Close
Infiti Logo

Hello there!

Contact us to know more about our cost-effective custom market research offerings to support efficient market penetration, new product launch, and devise strategies to monitor and outperform your competitors.

Cookie Policy

The Site uses cookies to record users' preferences in relation to the functionality of accessibility. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice